Here are 100 books that Jungle Laboratories fans have personally recommended if you like
Jungle Laboratories.
Shepherd is a community of 12,000+ authors and super readers sharing their favorite books with the world.
As a historian of science and medicine, I’m fascinated by the many ways that drugs—from tea to opiates, Prozac to psychedelics—have shaped our world. After all, there are few adults on the planet today who don’t regularly consume substances that have been classified as a drug at one time or another (I’m looking at you, coffee and tea!). The books I’ve selected here have deeply influenced my own thinking on the history of drugs over the past decade, from my first book, The Age of Intoxication, to my new book on the history of psychedelic science.
This ambitious and readable book explores how a seemingly simple beverage—tea—became a force shaping global empires. Rappaport, a historian at UC Santa Barbara, documents how tea has influenced everything from global trade networks and consumer cultures to ideas about health, morality, and national identity over the past three centuries.
Readers follow tea’s rise to become a key global commodity, moving from the courtly culture of tea in imperial China to the pages of Victorian magazines and the vast plantations of India and East Africa. This book made me think in a new way about the origins of modern-day consumer culture—not to mention the cup of tea I’m drinking as I write this.
How the global tea industry influenced the international economy and the rise of mass consumerism
Tea has been one of the most popular commodities in the world. For centuries, profits from its growth and sales funded wars and fueled colonization, and its cultivation brought about massive changes-in land use, labor systems, market practices, and social hierarchies-the effects of which are with us even today. A Thirst for Empire takes an in-depth historical look at how men and women-through the tea industry in Europe, Asia, North America, and Africa-transformed global tastes and habits. An expansive and original global history of imperial…
As a historian of science and medicine, I’m fascinated by the many ways that drugs—from tea to opiates, Prozac to psychedelics—have shaped our world. After all, there are few adults on the planet today who don’t regularly consume substances that have been classified as a drug at one time or another (I’m looking at you, coffee and tea!). The books I’ve selected here have deeply influenced my own thinking on the history of drugs over the past decade, from my first book, The Age of Intoxication, to my new book on the history of psychedelic science.
In this tour-de-force work of investigative journalism, New Yorker staff writer Patrick Radden Keefe traces the sordid history of the Sackler dynasty, the billionaire family behind Purdue Pharmaceuticals and its blockbuster narcotic painkiller OxyContin.
With both narrative verve and moral urgency—a combination that isn’t always easy to pull off—this book exposes one of the many points of origin for America’s devastating opioid epidemic. Keefe’s work has reinforced my conviction that drug historians have an important role to play in shaping public understanding and policy debates around these substances in the present. I found this book to be a page-turner and one of the most thoughtful books I’ve read in years.
NEW YORK TIMES BESTSELLER • A NEW YORK TIMES NOTABLE BOOK OF THE YEAR • A grand, devastating portrait of three generations of the Sackler family, famed for their philanthropy, whose fortune was built by Valium and whose reputation was destroyed by OxyContin. From the prize-winning and bestselling author of Say Nothing.
"A real-life version of the HBO series Succession with a lethal sting in its tail…a masterful work of narrative reportage.” – Laura Miller, Slate
The history of the Sackler dynasty is rife with drama—baroque personal lives; bitter disputes over estates; fistfights in boardrooms; glittering art collections; Machiavellian courtroom…
As a historian of science and medicine, I’m fascinated by the many ways that drugs—from tea to opiates, Prozac to psychedelics—have shaped our world. After all, there are few adults on the planet today who don’t regularly consume substances that have been classified as a drug at one time or another (I’m looking at you, coffee and tea!). The books I’ve selected here have deeply influenced my own thinking on the history of drugs over the past decade, from my first book, The Age of Intoxication, to my new book on the history of psychedelic science.
If I were asked to recommend just one book on the history of drugs, this would be it. Courtwright is an expert in the history of drugs in the nineteenth and twentieth-century United States, but in this book, he zooms out—way out—to think about the larger history of humanity’s relationship to mind-altering substances.
At the book's core is Courtwright’s influential concept of a “psychoactive revolution” that influenced the histories of empire, globalization, and science over the past five centuries. I have been deeply influenced by his approach ever since I first read this book in grad school, and I use it often in my teaching.
What drives the drug trade, and how has it come to be what it is today? A global history of the acquisition of progressively more potent means of altering ordinary waking consciousness, this book is the first to provide the big picture of the discovery, interchange, and exploitation of the planet's psychoactive resources, from tea and kola to opiates and amphetamines.
As a historian of science and medicine, I’m fascinated by the many ways that drugs—from tea to opiates, Prozac to psychedelics—have shaped our world. After all, there are few adults on the planet today who don’t regularly consume substances that have been classified as a drug at one time or another (I’m looking at you, coffee and tea!). The books I’ve selected here have deeply influenced my own thinking on the history of drugs over the past decade, from my first book, The Age of Intoxication, to my new book on the history of psychedelic science.
Mike Jay is the best writer I know of when it comes to highlighting the human stories behind the history of drugs. He is also fabulously engaging and original.
Jay’s most recent book is a compelling history of self-experimentation with drugs, which ranges from Romantic-era opium eaters like Thomas de Quincey to pioneer neuroscientists and Siberian shamans—and, of course, the hilariously weird nitrous oxide experiments of William James, who graces the book’s cover.
"Richly detailed and frequently illuminating."-Rhys Blakely, Times (UK)
"Excellent."-Clare Bucknell, New Yorker
A New Yorker Best of the Week Pick
A provocative and original history of the scientists and writers, artists and philosophers who took drugs to explore the hidden regions of the mind
Until the twentieth century, scientists investigating the effects of drugs on the mind did so by experimenting on themselves. Vivid descriptions of drug experiences sparked insights across the mind sciences, pharmacology, medicine, and philosophy. Accounts in journals and literary fiction inspired a fascinated public to make their own experiments-in scientific demonstrations,…
Frank S. David, MD, PhD leads the biopharma consulting firm Pharmagellan, where he advises drug companies and investors on R&D and business strategy. He is also an academic researcher on strategy, regulation, and policy in the drug industry; a member of the Harvard-MIT Center for Regulatory Science; and a former blogger at Forbes.com.
A key issue about drug pricing not covered in Kolchinsky's book relates to value: even if a new therapy is affordable, is it "worth it"? Health economist Peter Neumann and his colleagues have written an authoritative, insightful, and extremely accessible history of efforts to align drugs' prices with their benefits to patients and society. This is a must-read guide for both insiders and non-experts to a topic that will be at the forefront of the drug pricing debate in the coming decade.
The US prescription drug business is a $500 billion industry whose rising prices carry profound consequences for patients, caregivers, employers and taxpayers across the nation. In the United States, average prices of leading brand-name drugs are two to four times higher than prices charged in other wealthy countries, raising questions as to what Americans are getting for the extra expense. On the other hand, healthy industry returns have arguably fueled life-saving innovation. With the advent of ever more targeted and powerful treatments, including cell- and gene-based therapies with multi-million-dollar price tags, the need for sensible drug pricing policies will only…
In my younger days, as the son of a medical professor and a public health nurse, I was more interested in healing society than patients. But my political interests and research agenda as a professor of political science ultimately led back to medicine. I found that profit-maximizing market competition in health care failed miserably to promote value in therapeutics and economize on society’s scarce resources. I became aware of the neglect of public health to prevent disease for vulnerable groups in society and save money as well as lives. Pervasive and enduring economic conflicts of interest in the medical-industrial complex bear primary responsibility for severe deficits in quality, equality, and economy in American health care.
I found, as a history buff, The Struggle for Drug Reform to be an eye-opener about how America’s exceptionally high drug prices among other deficits in health care quality and coverage resulted from the past exercise of power by the pharmaceutical industry, the lynchpin of America’s “medico-industrial complex.”
I was impressed by historian Tobbell’s meticulously researched account of the industry’s strategic alliances with self-interested medical scientists, not just conservative political forces, and its use of anti-communist propaganda to fight off the threat of drug pricing regulations.
I personally found important her discussions of how the industry allied with the American Medical Association against universal health care, against FDA demands for evidence about drug efficacy and safety before allowing drugs on the market, and against the threat to its profits from generic drugs.
Since the 1950s, the American pharmaceutical industry has been heavily criticized for its profit levels, the high cost of prescription drugs, drug safety problems, and more, yet it has, together with the medical profession, staunchly and successfully opposed regulation. "Pills, Power, and Policy" offers a lucid history of how the American drug industry and key sectors of the medical profession came to be allies against pharmaceutical reform. It details the political strategies they have used to influence public opinion, shape legislative reform, and define the regulatory environment of prescription drugs. Untangling the complex relationships between drug companies, physicians, and academic…
As a cancer doctor, I have spent two decades dedicated to understanding the causes and therapy of cancer, how my patients experience their diagnosis and treatment, and how meaningful improvements in their experience should be reflected in the criteria we use to approve cancer drugs approval in the U.S., to improve their lives. In over 100 essays published in outlets like The New York Times and The Washington Post and in two books, I sing the stories of my patients as I learn from their undaunted spirits and their utter humanity, as I try to figure out how to be a better doctor, and a better person.
There’s a seedy side to the pharmaceutical industry that started well before the creation of the FDA, and continues through the modern era, fueling the epidemic of opioid drug dependency.
In Pharma, Posner’s comprehensive reporting introduces us to brilliant scientists, incorruptible government regulators, and brave whistleblowers facing off against company executives often blinded by greed.
We learn how the Sacklers built a culture of pain relief on the shoulders of oxycontin – one that ultimately led to the lowest survival rates for Americans in a century.
Award-winning journalist and New York Times bestselling author Gerald Posner traces the heroes and villains of the trillion-dollar-a-year pharmaceutical industry and uncovers how those once entrusted with improving life have often betrayed that ideal to corruption and reckless profiteering-with deadly consequences.
Pharmaceutical breakthroughs such as anti biotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on pre scription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning…
Frank S. David, MD, PhD leads the biopharma consulting firm Pharmagellan, where he advises drug companies and investors on R&D and business strategy. He is also an academic researcher on strategy, regulation, and policy in the drug industry; a member of the Harvard-MIT Center for Regulatory Science; and a former blogger at Forbes.com.
This account of the early years of Vertex Pharmaceuticals, from its inception as a scrappy start-up to its early work in HIV, is a must-read classic for anyone interested in how science turns into new drugs. Barry Werth’s journalistic play-by-play is a cinematic, true-to-life picture of the strategic decisions, real-world challenges, and larger-than-life personalities that underlie modern drug development. His riveting follow-up, The Antidote, continues the saga by taking readers through Vertex’s pathbreaking work to transform the care of patients with hepatitis C and cystic fibrosis.
As a published author, Debra’s passion for fast-paced, unputdownable novels is unquenchable. She can be ruthless in her criticism, applying the rule, “three strikes and you’re out!” A firm believer that life is too short to read mediocre books, if she isn’t grabbed by chapter 3, she puts the book down and moves on. She wants a book to make her life better, she wants to feel excitement at picking it back up again, and burying herself in the characters and moods, twists and turns, of a great story. Her writing reflects this same trait, if her words won’t keep the reader totally engrossed, then she won’t write them.
One of my all-time favourites I’ve read this book 3 times now and, after this review, I’m sure I’ll be tempted to indulge myself for a fourth time. Follett is the master of knife-edge thrillers, if you’ve never read him, start now. Full of treachery and violence, twists and revelations. It’s a scary, but utterly brilliant read.
"Everyone likes a page-turner, and Follett is the best." -The Philadelphia Inquirer
"A hell of a storyteller" (Entertainment Weekly), #1 New York Times bestselling author Ken Follett reinvents the thriller with each new novel. But nothing matches the intricate knife-edge drama of Whiteout. . . .
A missing canister of a deadly virus. A lab technician bleeding from the eyes. Toni Gallo, the security director of a Scottish medical research firm, knows she has problems, but she has no idea of the nightmare to come.
As a Christmas Eve blizzard whips out of the north, several people, Toni among them,…
In my younger days, as the son of a medical professor and a public health nurse, I was more interested in healing society than patients. But my political interests and research agenda as a professor of political science ultimately led back to medicine. I found that profit-maximizing market competition in health care failed miserably to promote value in therapeutics and economize on society’s scarce resources. I became aware of the neglect of public health to prevent disease for vulnerable groups in society and save money as well as lives. Pervasive and enduring economic conflicts of interest in the medical-industrial complex bear primary responsibility for severe deficits in quality, equality, and economy in American health care.
If you think that medical journals published by respected medical societies are full of good science, think again.
For me, Abramson’s Sickeningnailed the case for a conclusion that the net effect of the many hundreds of medical journals published here and around the world is to subtract from the sum of human medical knowledge.
Abramson, as an expert witness in criminal and civil cases against drug companies, draws in part on subpoenaed documents to expose how medical science, as part of the entire medical-industrial complex, is corrupted from start to finish by the drug industry’s funding of most clinical trials, their control over the data analysis, and even their ghost-writing of articles submitted to journals.
New and disturbing was the withholding of clinical trials’ raw data from journals’ peer reviewers. Instead, they get biased summaries bearing drug manufacturers’ fingerprints.
The inside story of how Big Pharma’s relentless pursuit of ever-higher profits corrupts medical knowledge—misleading doctors, misdirecting American health care, and harming our health.
The United States spends an excess $1.5 trillion annually on health care compared to other wealthy countries—yet the amount of time that Americans live in good health ranks a lowly 68th in the world. At the heart of the problem is Big Pharma, which funds most clinical trials and therefore controls the research agenda, withholds the real data from those trials as corporate secrets, and shapes most of the information relied upon by health care professionals.…
